Related Experiment Videos
Developing a national system for dealing with adverse events following immunization.
U Mehta1, J B Milstien, P Duclos
1National Adverse Drug Event Monitoring Centre, University of Cape Town, Observatory, South Africa. umehta@uctgsh1.uct.ac.za
Bulletin of the World Health Organization
|April 1, 2000
Summary
Establishing robust national vaccine safety monitoring and reporting systems is crucial for public health. This includes efficient coordination with pharmaceutical safety systems and public communication strategies for adverse events.
Area of Science:
- Public Health
- Pharmaceutical Safety
- Vaccinology
Background:
- Vaccines are generally safe, but severe adverse events can pose public health threats.
- Existing pharmaceutical safety monitoring may not adequately address vaccine-specific concerns.
- Public trust and rapid risk assessment are vital during adverse event investigations.
Purpose of the Study:
- To outline a simple national system for managing vaccine safety and emergencies.
- To describe the goals of a training program for developing such a system.
- To enhance global vaccine safety surveillance capabilities.
Main Methods:
- The World Health Organization (WHO) Global Training Network developed a national system framework.
- The framework focuses on simple, coordinated monitoring and reporting mechanisms.
- Training program goals were defined to support system implementation.
Main Results:
- A model for a national vaccine safety and emergency management system was described.
- Key components for training programs to build these systems were identified.
- Emphasis was placed on integrating vaccine safety with broader pharmaceutical safety.
Conclusions:
- Effective national systems are essential for managing vaccine safety and public concerns.
- Coordinated monitoring and reporting are critical for timely risk assessment.
- Training initiatives can strengthen a nation's capacity to ensure vaccine safety.